✦ LIBER ✦

Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma

✍ Scribed by Francesca Gay; S. Vincent Rajkumar; Patrizia Falco; Shaji Kumar; Angela Dispenzieri; Maria Teresa Petrucci; Morie A. Gertz; Mario Boccadoro; A. Keith Stewart; Antonio Palumbo

Book ID: 114794794
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 268 KB
Volume: 85
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2010.01469.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enoxaparin or aspirin for the prevention

Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide

✍ A. PALUMBO; C. RUS; J. B. ZELDIS; F. RODEGHIERO; M. BOCCADORO; THE ITALIAN MULTI 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

PSY19 THE COST-EFFECTIVENESS OF BORTEZOM

PSY19 THE COST-EFFECTIVENESS OF BORTEZOMIB PLUS MELPHALAN AND PREDNISONE VERSUS LENALIDOMIDE PLUS MELPHALAN AND PREDNISONE WITH CONTINUOUS LENALIDOMIDE MAINTENANCE TREATMENT FOR THE INITIAL TREATMENT OF MULTIPLE MYELOMA IN THE UNITED STATES

✍ S.T. Wang; H. Huang; A. Ba-mancini; H. Shi; K. Chen; C. Korves; R. Dhawan; A. Ca 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

(Bortezomib plus lenalidomide/thalidomid

(Bortezomib plus lenalidomide/thalidomide)- vs (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials

✍ Wang, Anyou; Duan, Qiaohong; Liu, Xin; Ding, Kaiyang; Han, Yongsheng; Zhu, Weibo 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 777 KB

Perifosine plus lenalidomide and dexamet

Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study

✍ Andrzej J. Jakubowiak; Paul G. Richardson; Todd Zimmerman; Melissa Alsina; Jonat 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Bortezomib with thalidomide plus dexamet

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

✍ Michele Cavo; Paola Tacchetti; Francesca Patriarca; Maria Teresa Petrucci; Lucia 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 276 KB

Cyclophosphamide plus dexamethasone is a

Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma : Results of a randomized comparison with vincristine, doxorubicin, and dexamethasone

✍ Ulf-Henrik Mellqvist; Stig Lenhoff; Hans E. Johnsen; Martin Hjorth; Erik Holmber 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

## Abstract ## BACKGROUND Today, intensive therapy that includes high‐dose melphalan with autologous stem cell transplantation (ASCT) is considered standard therapy in younger patients with newly diagnosed myeloma. When the current trial was initiated, combined vincristine, doxorubicin, and dexame